|4Jan 7, 5:32 PM ET

Burrows Francis 4

4 · Kura Oncology, Inc. · Filed Jan 7, 2025

Insider Transaction Report

Form 4
Period: 2025-01-02
Burrows Francis
Chief Scientific Officer
Transactions
  • Award

    Option to purchase common stock

    2025-01-02+185,000185,000 total
    Exercise: $8.68Exp: 2035-01-01Common Stock (185,000 underlying)
Footnotes (1)
  • [F1]The option vests in 48 equal monthly installments commencing on the grant date.

Documents

1 file
  • 4
    form4-01072025_100138.xmlPrimary